BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3018099)

  • 1. The biology of human cytomegalovirus infection after bone marrow transplantation.
    Zaia JA
    Int J Cell Cloning; 1986; 4 Suppl 1():135-54. PubMed ID: 3018099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation.
    Buchbinder S; Elmaagacli AH; Schaefer UW; Roggendorf M
    Bone Marrow Transplant; 2000 Sep; 26(6):639-44. PubMed ID: 11035370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative detection of human cytomegalovirus DNA in the plasma of bone marrow transplant recipients: value as a predictor of disease progression.
    Behzad-Behbahani A; Ehsanipour F; Alborzi A; Nourani H; Ramzi M; Rasoli M
    Exp Clin Transplant; 2004 Jun; 2(1):196-200. PubMed ID: 15859928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
    Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.
    Ziyaeyan M; Sabahi F; Alborzi A; Mahboudi F; Kazemnejad A; Ramzi M; Moravej A; Jaberi MM
    Exp Clin Transplant; 2006 Jun; 4(1):470-4. PubMed ID: 16827646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection after bone marrow transplantation in children.
    Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
    Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products.
    Rubie H; Attal M; Campardou AM; Gayet-Mengelle C; Payen C; Sanguignol F; Calot JP; Charlet JP; Robert A; Huguet F
    Bone Marrow Transplant; 1993 Mar; 11(3):209-14. PubMed ID: 8385522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT.
    Trenschel R; Ross S; Hüsing J; Ottinger H; Elmaagacli A; Roggendorf M; Schaefer UW; Runde V
    Bone Marrow Transplant; 2000 Mar; 25(6):665-72. PubMed ID: 10734302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
    Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A
    Bone Marrow Transplant; 1996 Apr; 17(4):583-7. PubMed ID: 8722359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Lengerke C; Ljubicic T; Meisner C; Loeffler J; Sinzger C; Einsele H; Hebart H
    Bone Marrow Transplant; 2006 Jul; 38(1):53-60. PubMed ID: 16788683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of human cytomegalovirus DNA from allogeneic bone marrow transplant recipients with interstitial pneumonitis.
    Takagi N; Hasegawa Y; Ichiyama S; Nomura F; Hirabayashi N; Shimokata K
    Am J Med Sci; 1996 Jul; 312(1):1-7. PubMed ID: 8686723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring transplant patients for human cytomegalovirus: Diagnostic update.
    Gerna G; Lilleri D
    Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT.
    Hertenstein B; Hampl W; Bunjes D; Wiesneth M; Duncker C; Koszinowski U; Heimpel H; Arnold R; Mertens T
    Bone Marrow Transplant; 1995 Mar; 15(3):387-93. PubMed ID: 7599563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus infection after orthotopic liver transplantation is restricted by a pre-existing antiviral immune response of the recipient.
    Bissinger AL; Oettle H; Jahn G; Neuhaus P; Sinzger C
    J Med Virol; 2004 May; 73(1):45-53. PubMed ID: 15042647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and practical value of human cytomegalovirus DNAemia detection by semi-nested PCR for follow-up of BMT recipients.
    Imbert-Marcille BM; Milpied N; Coste-Burel M; Richet B; Moreau P; Harousseau JL; Billaudel S
    Bone Marrow Transplant; 1995 Apr; 15(4):611-7. PubMed ID: 7655389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
    Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
    Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
    Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    Transplantation; 2003 Jun; 75(12):2064-8. PubMed ID: 12829913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.